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Abstract
Non-uniform shortening of the action potential duration (APD90) in different myocardial
regions upon heart rate acceleration can set abnormal repolarization gradients and promote
arrhythmia. This study examined whether spatial heterogeneities in APD90 restitution can
be amplified by drugs with clinically proved proarrhythmic potential (dofetilide, quinidine,
procainamide, and flecainide) and, if so, whether these effects can translate to the appropri-
ate changes of the ECG metrics of ventricular repolarization, such as JT intervals. In iso-
lated, perfused guinea-pig heart preparations, monophasic action potentials and volume-
conducted ECG were recorded at progressively increased pacing rates. The APD90 mea-
sured at distinct ventricular sites, as well as the JTpeak and JTend values were plotted as a
function of preceding diastolic interval, and the maximum slopes of the restitution curves
were determined at baseline and upon drug administration. Dofetilide, quinidine, and procai-
namide reverse rate-dependently prolonged APD90 and steepened the restitution curve,
with effects being greater at the endocardium than epicardium, and in the right ventricular
(RV) vs. the left ventricular (LV) chamber. The restitution slope was increased to a greater
extent for the JTend vs. the JTpeak interval. In contrast, flecainide reduced the APD90 resti-
tution slope at LV epicardium without producing effect at LV endocardium and RV epicar-
dium, and reduced the JTpeak restitution slope without changing the JTend restitution.
Nevertheless, with all agents, these effects translated to the amplified epicardial-to-endocar-
dial and the LV-to-RV non-uniformities in APD90 restitution, paralleled by the increased
JTend vs. JTpeak difference in the restitution slope. In summary, these findings suggest
that arrhythmic drug profiles are partly attributable to the accentuated regional heterogene-
ities in APD90 restitution, which can be indirectly determined through ECG assessments of
the JTend vs. JTpeak dynamics at variable pacing rates.
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Introduction
In susceptible patients, antiarrhythmic drug therapies can paradoxically precipitate malignant
ventricular tachyarrhythmia, torsade de pointes, thereby increasing mortality rates [1]. The
proarrhythmic responses most frequently occur with class Ia and Ic Na+ channel blockers, and
class III agents that block IKr, the rapid component of the delayed rectifier. For instance, the
DIAMOND clinical trial has raised serious concerns regarding torsadogenic effects produced
by dofetilide, class III antiarrhythmic agent, in patients with congestive heart failure [2]. In the
CAST trial, an increase in sudden arrhythmic death was observed upon administration of fle-
cainide, class Ic Na+ channel blocker, in patients with healed myocardial infarction [3]. An
increased occurrence of torsade de pointes has also been reported in studies that utilized class
Ia agents, quinidine and procainamide [4–5].
Drug-induced cardiac electrical instability often develops unexpectedly, and its early detec-
tion is difficult due to the limited prognostic value of the existing arrhythmic biomarkers.
Recently, the electrical restitution analysis has been proposed as a novel approach for evalua-
tion of the drug safety profile [6–7]. When ventricular action potential duration (APD) is plot-
ted vs. the diastolic interval, arrhythmic effects can be predicted via two modifications,
namely, the increased maximum slope of the APD restitution curve, and the amplified disper-
sion of the restitution slope value determined at different ventricular recording sites. Steep
electrical restitution precipitates beat-to-beat oscillations in APD (electrical alternans) during
tachycardia, whereas non-uniform APD shortening at distinct myocardial regions sets abnor-
mal spatial repolarization gradients; both mechanisms, therefore, can facilitate localized con-
duction block leading to the wavebreak and ventricular fibrillation.
Although drug-induced arrhythmia was partly attributed to the steepening of the electrical
restitution in some studies [8–12], the putative contribution of the amplified spatial heteroge-
neities in restitution kinetics to the arrhythmic drug profile has not been examined yet. Like-
wise, it remains uncertain as to whether modified spatial heterogeneities of the APD
restitution upon drug administration can translate to appropriate changes of the ECG metrics
of ventricular repolarization, such as JT intervals. The JTpeak and the JTend intervals are
thought to reflect the shortest and the longest action potential duration, respectively, when
repolarization is assessed at multiple recording sites across LV wall [13], or along the trans-
mural and apicobasal axes in both ventricular chambers [14–17]. Therefore, it can be hypothe-
sized that the difference in the maximum slope of the JTpeak vs. JTend restitution would
roughly approximate ventricular site-dependent variations of the APD restitution slope value,
upon drug infusions.
With these considerations in mind, the present study examined effects of four pharmaco-
logical agents with clinically proved arrhythmogenic effects (dofetilide, quinidine, procaina-
mide, and flecainide) on the spatial heterogeneities in APD restitution and the JTpeak vs.
JTend difference in the restitution slope, in isolated, perfused guinea-pig hearts.
Materials and methods
This study complies with the European Community Guidelines for the Care and Use of Exper-
imental Animals, and was approved by the Animal Ethics Screening Committee of the Panum
Institute (clearance number: 2010/561-1799).
Isolated, Langendorff-perfused heart preparations
The heart preparations were obtained from female Dunkin-Hartley guinea-pigs, assuming that
females have reduced cardiac repolarization reserve and therefore more susceptible to drug-
induced proarrhythmia, as compared to males [18]. The experiments on isolated, perfused
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hearts were performed as described previously [19–20]. The guinea-pigs (body weight 400–
500 g) were anesthetized with sodium pentobarbital (50 mg/kg i.p.) and anticoagulated with
heparin (1000 IU/kg i.p.). The chest was opened, the hearts were immediately excised,
mounted on a Langendorff perfusion set-up (Hugo Sachs Elektronik-Harvard Apparatus
GmbH, March-Hugstetten, Germany) and perfused via the aorta at a constant flow (15 ml/
min) with carefully filtered, warmed physiological saline solution saturated with 95%O2 and
5%CO2. The perfusion solution contained (in mM) 118.0 NaCl; 4.7 KCl; 2.5 CaCl2; 25
NaHCO3; 1.2 KH2PO4; 1.2 MgSO4; and 10.0 glucose, and had a pH of 7.4. The aortic perfusion
pressure (65–70 mm Hg) was measured with a ISOTEC pressure transducer and the coronary
flow rate was determined using an ultrasonic flowmeter probe (Transonic Systems Inc., USA)
placed just above the aortic cannula. The electrical activity of the heart preparations was
assessed from the volume-conducted ECG as well as monophasic action potential recordings.
Throughout the experiments, the heart preparations were kept immersed in the temperature-
controlled, perfusate-filled chamber to minimize thermal loss. Aortic pressure, coronary flow
rate, ECG and monophasic action potentials were continuously monitored using the 16-chan-
nel PowerLab system (ADInstruments, Oxford, UK).
Electrophysiological recordings
In order to slow the intrinsic beating rate and enable ventricular pacing over a wide range of
diastolic intervals, both atria were removed and the atrioventricular (AV) node was crushed
mechanically with forceps prior to taking electrophysiological recordings. Monophasic action
potentials (MAP) were obtained from the endocardial and the opposite epicardial recording
sites at the base of the left ventricular (LV) lateral wall, and from the right ventricular (RV)
epicardial base (Fig 1, panels A and C) using spring-loaded pressure contact electrodes (Hugo
Sachs Electronik-Harvard Apparatus GmbH, March-Hugstetten, Germany). The MAP dura-
tion was measured at 90% repolarization (APD90). Electrical stimulations were applied at LV
epicardium close to the adjacent MAP recording electrode using 2 ms rectangular pulses of
twice diastolic threshold current generated by a programmable stimulator (Hugo Sachs Elec-
tronik-Harvard Apparatus GmbH, March-Hugstetten, Germany). LV pacing thresholds were
measured both at baseline and upon drug infusion, and the stimulating current strength was
adjusted appropriately whenever necessary.
On the volume-conducted ECG, JT intervals were measured from the end of the QRS com-
plex (J point) to the peak of the T wave (JTpeak interval), and to the end of the T wave (JTend
interval) (Fig 1, panel B).
Electrical restitution
The electrical restitution kinetics was assessed using the steady-state pacing protocol [10–12].
In brief, a train of 50 pulses was applied, and the MAP duration at distinct ventricular record-
ing sites, as well as JTpeak and JTend intervals on ECG were determined in the last beat in a
train, while progressively decreasing the S1-S1 pacing interval in successive stimulations. The
measurements were started with a S1-S1 cycle length of 550 ms (the longest pacing interval pro-
ducing no ventricular escape beats), which was then reduced to 500 ms, followed by further
reductions in steps of 20 ms over an S1-S1 range from 500 to 200 ms, and by 5–10 ms reduc-
tions from 200 ms down to the pacing intervals (about 170 ms) producing 2:1 conduction
block. In AV-blocked preparations, the minimum pacing intervals achieved with this protocol
remain significantly greater than the threshold value of S1-S1 interval for inducing repolariza-
tion alternans (90–100 ms in intact guinea-pig heart) [21], meaning that the whole pacing pro-
tocol could have been completed without inducing cardiac electrical instability.
Electrical restitution and arrhythmia
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Fig 1. Basal electrophysiological recordings and the restitution of ventricular action potential duration and JT intervals. Panel A
shows representative ECG and monophasic action potentials (MAP) recorded at the left ventricular (LV) epicardium (epi), LV
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Once the electrical stimulations were completed, appropriate diastolic intervals (DI) were
calculated as a difference between the S1-S1 cycle length and the measured APD90 (APD90 res-
titution) or JTpeak and JTend interval (JT restitution) values. The electrical restitution was
analysed by plotting APD90 and JT intervals as a function of the preceding DI. The restitution
curves were fitted using double-exponential function: y = y0 + A1exp
(-DI/τ1) + A2exp
(-DI/τ2),
where y represents APD90 or JT interval value, y0 is a free-fitting variable, A1 and A2 are the
amplitudes, and τ1 and τ2 are the time constants of the fast (A1 and τ1) and slow (A2 and τ2)
exponential components obtained by a least squares fit. The curve fitting was performed using
Igor Pro 6.0 software (WaveMetrics, Inc., Portland, OR, USA).
The obtained exponential curves were differentiated to determine the maximum restitution
slope value (Fig 1, panels D-G). Thereafter, spatial dispersion in APD90 restitution kinetics was
assessed by calculating the difference between the maximum restitution slopes measured at LV
endocardium vs. LV epicardium, and those measured at RV epicardium vs. LV epicardium.
With ECG recordings, the difference between the maximum slopes obtained from JTend vs.
JTpeak restitution curves was taken as an ECG estimate of the regional ventricular heterogene-
ities in electrical restitution.
Drug infusions
In total, 30 heart preparations were used in this study, in order to examine effects produced by
dofetilide, quinidine, procainamide, and flecainide (7–8 experiments in each study group). For
precise dosing, drug infusions were performed at a rate of 0.3 ml/min using a calibrated infu-
sion pump, while perfusing the hearts with protein-free saline solution at a constant coronary
flow rate (see above). Dofetilide (10 nM), quinidine (5 μM), procainamide (10 μM), and flecai-
nide (1.5 μM) (all from Sigma-Aldrich, Germany) were infused over 30 min, at concentrations
close to the maximum free (i.e. protein-unbound) therapeutic plasma levels [22–25] (S1
Table).
Data analysis
Data are expressed as mean ± standard error of the mean. One-way ANOVA was used for
multiple comparisons, and paired t-tests were used to compare two data sets. P values less than
0.05 were considered to be significant.
Results
Restitution of APD90 and JT intervals in basal conditions
Fig 1 shows representative ECG and monophasic action potential recordings (panel A), and
the summary data for the restitution of ventricular APD90 (panels D and E) and JT intervals
(panels F and G) obtained prior to drug infusion in heart preparations from all experimental
groups. Over a range of variable diastolic intervals, action potential duration was found to be
5–10 ms shorter at LV epicardium compared to the corresponding LV endocardial or RV
epicardial APD90 values (Fig 1, panel D). On the ECG, JTpeak interval was about 20 ms shorter
endocardium (endo), and the right ventricular (RV) epicardium upon S1-S1 pacing at a cycle length of 550 ms. The moments of S1
application are shown by vertical dotted lines on the MAP traces. The first beat from ECG recording in panel A is shown at a larger scale
on panel B in order to illustrate the measurements of the JTpeak and JTend intervals. Panel C shows location of the MAP recording
electrodes (open circles), and the LV stimulating (Stim) electrode (filled circle). Panels D and F show averaged action potential durations
(APD90) measured at distinct ventricular regions (panel D), and the JTpeak and JTend intervals determined from ECG (panel F) during
cardiac pacing at variable diastolic intervals (DI) prior to drug infusion in 30 experiments. The slope values obtained from the APD90
and JT restitution (rest) curves are plotted in panels E and G, respectively.
https://doi.org/10.1371/journal.pone.0191514.g001
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than JTend interval (Fig 1, panel F). A decrease in LV pacing cycle length from 550 ms to 168
±2 ms (the minimum S1-S1 interval with preserved LV capture) provoked an exponential
reduction of both ventricular APD90 and JT intervals, whereby the steepness of the electrical
restitution curves was progressively increasing upon a reduction of the diastolic interval (Fig 1,
panels E and G). Importantly, the maximum slope of APD90 restitution, attained at the shortest
DI, was greater at LV endocardium (0.73±0.03) and RV epicardium (0.69±0.03) compared to
the slope determined at LV epicardium (0.57±0.02) (Fig 1, panel E; P = 0.0001), indicating the
presence of spatial heterogeneities in electrical restitution, both over LV transmural and RV-
to-LV transepicardial planes. With ECG recordings, the maximum restitution slope was
greater for JTend interval (0.91±0.05) compared to JTpeak interval (0.58±0.02) (Fig 1, panel G;
P<0.0001), thus providing an ECG correlate for assessments of the regional non-uniformities
in electrical restitution.
Dofetilide
APD90 restitution. Fig 2 shows dofetilide effects on APD90-to-DI relations assessed at dif-
ferent ventricular regions. Dofetilide significantly prolonged repolarization at LV endocar-
dium, LV epicardium, and RV epicardium, thus causing the APD90 restitution curves to shift
upwards (Fig 2, panels A, B, and C). An increase in APD90 by dofetilide was markedly accentu-
ated at the long (above 250 ms) as compared to the short (less than 100 ms) diastolic intervals,
which contributed to the steepening of the restitution curve, as evidenced by increased maxi-
mum slope values, at each ventricular recording site (Fig 2, panels D, E, and F).
The reverse rate-dependent effect of dofetilide was quantified by calculating the difference
in APD90 increase obtained at the maximum as compared to the minimum diastolic intervals.
For example, at LV endocardium (Fig 2, panel A), dofetilide prolonged APD90 from 168±3 ms
to 195±5 ms at the maximum DI (~380 ms), while increasing APD90 from 140±3 ms to 146±4
ms at the minimum DI (~50 ms). The difference in APD90 lengthening produced by dofetilide
at the maximum DI vs. the minimum DI (27 ms vs. 6 ms) therefore amounted 21±2 ms. At LV
epicardium (Fig 2, panel B), the difference in drug-induced APD90 lengthening determined at
the maximum DI vs. the minimum DI (22 ms vs. 14 ms) was found to be only 8±1 ms, whereas
at RV epicardium (Fig 2, panel C) this difference (18 ms vs. 6 ms) amounted 12±1 ms.
In connection with the spatial variations in the reverse rate-dependent effect on APD90,
dofetilide produced a greater increase in the maximum slope of electrical restitution at LV
endocardium (from 0.65±0.06 to 0.90±0.08) compared to LV epicardium (from 0.51±0.05 to
0.65±0.06) (Fig 2, panels D and E). As a result, the endocardial-to-epicardial difference in
APD90 restitution slope determined at baseline was further amplified by dofetilide (Fig 2,
panel G). Likewise, a greater steepening of the APD90 restitution curve by dofetilide was pro-
duced at RV epicardium (the maximum slope increased from 0.69±0.06 to 0.96±0.09) com-
pared to LV epicardium (Fig 2, panels E and F), thus increasing the RV-to-LV dispersion in
the restitution slope value (Fig 2, panel H).
JT restitution. Fig 3 (the left set of panels) shows dofetilide effects on the dynamics of JT
intervals at variable pacing rates. Dofetilide prolonged the JTpeak and JTend intervals in the
reverse rate-dependent manner (Fig 3, panels A and E), and increased the steepness of the
JTpeak and JTend restitution curves (Fig 3, panels C and G). The JTpeak interval (Fig 3, panel
A) was prolonged at the maximum DI by 36 ms (from 136±2 ms to 172±3 ms), and at the min-
imum DI by 29 ms (from 103±2 ms to 132±2 ms). The JTend interval (Fig 3, panel E), was pro-
longed at the maximum DI by 39 ms (from 160±2 ms to 199±3 ms), and at the minimum DI
by 26 ms (from 119±2 ms to 145±2 ms). The difference in JT prolongation obtained at the
maximum DI vs. the minimum DI was larger with JTend (13±1 ms) compared to JTpeak
Electrical restitution and arrhythmia
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interval (7±1 ms). Accordingly, a greater increase in the maximum restitution slope by dofeti-
lide was observed with JTend interval (from 0.70±0.06 to 1.08±0.09) compared to JTpeak
interval (from 0.42±0.04 to 0.68±0.06) (Fig 3, panels C and G). These changes contributed to
significantly increased JTend vs. JTpeak difference in the maximum restitution slope value
upon dofetilide administration (Fig 3, panel I).
Quinidine and procainamide
APD90 restitution. Figs 4 and 5 show effects of quinidine and procainamide, respectively,
on APD90-to-DI relations assessed at different ventricular regions. Both agents produced a
reverse rate-dependent prolongation of ventricular repolarization, and modulated APD90 res-
titution in the same way as dofetilide. With quinidine (Fig 4, panels A, B, and C), the difference
in APD90 change obtained at the maximum DI vs. the minimum DI was found to be larger at
LV endocardium (12±1 ms) and RV epicardium (11±1 ms) compared to that determined at
LV epicardium (8±1 ms). With procainamide (Fig 5, panels A, B, and C), the corresponding
values amounted 9±1 ms (LV endocardium), 7±1 ms (RV epicardium), and 4±1 ms (LV
Fig 2. Effects of dofetilide on the restitution of action potential duration assessed at distinct ventricular recording sites. Action potential duration (APD90) was
measured at baseline and upon drug infusion at the left ventricular (LV) endocardium (endo) (panel A), LV epicardium (epi) (panel B), and the right ventricular (RV)
epicardium (panel C), and then plotted as a function of preceding diastolic interval (DI). The APD90 restitution (rest) curves were differentiated in order to determine the
maximum restitution slope value attained at the shortest DI (panels D, E, and F). Panel G shows the difference in the maximum restitution slope determined at LV
endocardium vs. LV epicardium. Panel H shows the difference in the maximum restitution slope determined at RV vs. LV epicardium. P<0.05 vs. basal value (in panels
G and H).
https://doi.org/10.1371/journal.pone.0191514.g002
Electrical restitution and arrhythmia
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Fig 3. Effects of dofetilide and quinidine on the restitution of JTpeak and JTend intervals. JTpeak (panels A and B) and
JTend (panels E and F) intervals were measured on ECG at variable pacing rates, both at baseline and upon drug infusion, and
plotted as a function of preceding diastolic interval (DI). The JTpeak and JTend restitution (rest) curves were differentiated in
Electrical restitution and arrhythmia
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epicardium). Ventricular site-dependent variations in drug effects on APD90 translated to a
greater steepening of the electrical restitution curve at LV endocardium than at LV epicar-
dium, and in RV compared to LV chamber, upon infusion of quinidine and procainamide
(panels D, E, and F in Figs 4 and 5). Consequently, both LV endocardial-to-epicardial and RV-
to-LV epicardial dispersion of the maximum APD90 restitution slope was increased by these
agents (panels G and H in Figs 4 and 5).
JT restitution. Fig 3 (the right set of panels) and Fig 6 (the left set of panels) show effects
of quinidine and procainamide, respectively, on the restitution of JT intervals. Quinidine and
procainamide reverse rate-dependently prolonged the JTpeak and JTend intervals, and
increased the steepness of the JTpeak and JTend restitution curves. With both agents, the dif-
ference in the relative JTend change obtained at the maximum DI vs. the minimum DI (Quini-
dine: 18±2 ms; Procainamide: 10±1 ms) was found to exceed the corresponding difference in
JTpeak change (Quinidine: 11±1 ms; Procainamide: 6±1 ms). Accordingly, a greater steepen-
ing of the restitution curve was observed with JTend compared to JTpeak intervals upon
order to determine the maximum restitution slope value attained at the shortest DI (panels C, D, G, and H). Drug effects on the
JTpeak vs. JTend difference in the maximum restitution slope are shown in panel I (dofetilide) and panel J (quinidine). P<0.05
vs. basal value (in panels I and J).
https://doi.org/10.1371/journal.pone.0191514.g003
Fig 4. Effects of quinidine on the restitution of action potential duration assessed at distinct ventricular recording sites.
https://doi.org/10.1371/journal.pone.0191514.g004
Electrical restitution and arrhythmia
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infusion of quinidine (Fig 3, panels D and H) and procainamide (Fig 6, panels C and G).
These disproportional changes resulted in the amplified JTend vs. JTpeak dispersion of the
maximum restitution slope upon administration of quinidine (Fig 3, panel J) and procaina-
mide (Fig 6, panel I).
Flecainide
APD90 restitution. Fig 7 shows flecainide effects on APD90-to-DI relations determined at
the three ventricular recording sites. Flecainide produced a comparable increase in APD90 at
the maximum DI vs. the minimum DI, when assessed at LV endocardium and RV epicardium.
For example, at LV endocardium (Fig 7, panel A), APD90 was prolonged by 17 ms (from 169
±3 ms to 186±3 ms) at the maximum DI, and by 19 ms (from 131±2 ms to 150±3 ms) at the
minimum DI. At RV epicardium (Fig 7, panel C), the corresponding APD90 increase
amounted 6 ms at the maximum DI, and 8 ms at the minimum DI. These effects resulted in no
change in the maximum APD90 restitution slope determined at LV endocardium (Basal: 0.73
±0.06; Flecainide: 0.78±0.06) and RV epicardium (Basal: 0.71±0.06; Flecainide: 0.74±0.06) (Fig
7, panels D and F). In contrast, at LV epicardium (Fig 7, panel B), the relative increase in
APD90 produced by flecainide at the minimum DI (19 ms, from 124±2 ms to 143±2 ms) was
more prominent than that produced at the maximum DI (13 ms, from 160±2 ms to 173±2
ms). This resulted in flattening of the restitution curve obtained at LV epicardium (Fig 7, panel
E), as evidenced by a reduction in the maximum slope from 0.62±0.05 to 0.42±0.04 (P = 0.01).
No change in the maximum restitution slope determined at LV endocardium and RV epicar-
dium, in association with the reduced slope value at LV epicardium, translated to the increased
spatial heterogeneities in electrical restitution upon flecainide administration, both over LV
transmural and RV-to-LV epicardial planes (Fig 7, panels G and H, respectively).
Fig 5. Effects of procainamide on the restitution of action potential duration assessed at distinct ventricular recording sites.
https://doi.org/10.1371/journal.pone.0191514.g005
Electrical restitution and arrhythmia
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Fig 6. Effects of procainamide and flecainide on the restitution of JTpeak and JTend intervals.
https://doi.org/10.1371/journal.pone.0191514.g006
Electrical restitution and arrhythmia
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JT restitution. Fig 6 (the right set of panels) shows flecainide effects on the restitution of
JT intervals. Flecainide prolonged JTend interval (Fig 6, panel F) by 17 ms, both at the maxi-
mum DI (JTend change: from 158±2 ms to 175±1 ms) and at the minimum DI (JTend change:
from 118±1 ms to 135±1 ms). The uniform increase in JTend interval at variable pacing rates
translated to no drug effect on the maximum slope of the JTend restitution curve (Basal: 0.87
±0.07; Flecainide: 0.90±0.07) (Fig 6, panel H). In contrast, an increase in JTpeak interval (Fig
6, panel B) produced by flecainide tended to be greater at the minimum DI (14 ms, from 102
±1 ms to 116±3 ms) compared to the maximum DI (10 ms, from 138±1 ms to 148±1 ms), thus
causing the JTpeak restitution curve to flatten (Fig 6, panel D). The maximum JTpeak restitu-
tion slope was reduced from 0.61±0.05 to 0.43±0.04 (P = 0.01) by flecainide. No change in
JTend restitution kinetics, in association with reduced JTpeak restitution slope, resulted in
amplified JTend vs. JTpeak difference in the maximum restitution slope value (Fig 6, panel J).
Discussion
The main findings from the present study are twofold. First, it is shown that LV transmural
and RV-to-LV epicardial dispersion of the maximum APD90 restitution slope is amplified by
drugs that reportedly produce arrhythmic responses in the clinical setting (dofetilide, quini-
dine, procainamide, and flecainide). Second, the study demonstrates that an increase in
regional APD90 restitution heterogeneities translates to the increased JTpeak vs. JTend
Fig 7. Effects of flecainide on the restitution of action potential duration assessed at distinct ventricular recording sites.
https://doi.org/10.1371/journal.pone.0191514.g007
Electrical restitution and arrhythmia
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difference in the maximum restitution slopes determined from ECG recordings at variable
pacing rates.
Electrical restitution and arrhythmogenesis
Electrical restitution refers to the rate-dependent shortening of ventricular repolarization,
which is attributed to incomplete deactivation of IKr and IKs (the rapid and the slow compo-
nents of the delayed rectifier, respectively), and to the increased intracellular Na+ and Ca2+
concentrations at rapid cardiac activation rates [26–27]. The latter changes can decrease APD
via effects on the Na+-Ca2+ exchanger and Na+-K+ pump, and through the Ca2+-induced inac-
tivation of ICa in cardiac myocytes.
A steep slope of APD rate adaptation has been shown to facilitate ventricular fibrillation by
inducing APD and Ca2+ transient alternans in cardiac myocytes [6–7, 28]. The clinical rele-
vance of this mechanism, nevertheless, was challenged in studies that demonstrate no differ-
ence in the maximum APD restitution slope determined in patients with structural heart
disease susceptible to arrhythmia compared to the control subjects [29–30]. Likewise, the max-
imum restitution slope reportedly has no prognostic value at predicting arrhythmic death over
long-term follow-up [29, 31]. These findings therefore suggest the importance of restitution
parameters other than the maximum slope in the mechanisms of arrhythmogenesis.
Owing to the spatial heterogeneities in expression and function of repolarizing ionic cur-
rents [32], the amount of the rate-dependent APD shortening is variable at distinct ventricular
regions [33–34]. In the human heart, the APD restitution slopes are distributed non-uniformly
throughout both the epicardial and endocardial surface, and there is a considerable LV-to-RV
difference in the averaged steepness of the restitution curve [35–36]. Across LV wall, the APD
restitution slope is steeper at midmyocardium compared to subepicardial and subendocardial
regions in non-failing human hearts [37]. Spatial non-uniformities in electrical restitution are
markedly accentuated in patients with inducible tachyarrhythmia compared to those without
arrhythmia [30, 38], and in experimental studies, they can be amplified by proarrhythmic
interventions such as sympathetic neural stimulation [39] and global ischemia [40]. Following
a sudden reduction of the diastolic interval, for example, imposed by a premature ectopic acti-
vation, a greater APD shortening at the ventricular site with a steeper restitution slope com-
pared to the adjacent site with a shallower slope can contribute to the reversal of the local
repolarization gradient, and provide a substrate for re-entry [33, 41]. In this regard, there is a
strong evidence to demonstrate that a wavebreak precipitating sustained arrhythmia can occur
in the absence of steepened APD restitution, providing that spatial dispersion of the restitution
slope exceeds a certain critical level [34, 42]. These studies therefore raise the point that ampli-
fied regional restitution heterogeneities represent an independent arrhythmic determinant
that should be considered in assessments of the drug safety profile.
Basal spatial restitution heterogeneities in guinea-pig heart
The present study reports on significant regional restitution heterogeneities in guinea-pig
heart, wherein the maximum slope of APD restitution is greater at the endocardium vs. the
epicardium, and in the RV vs. the LV chamber (Fig 1, panels D and E). These results are likely
accounted for by the site-dependent variations in density of the outward K+ currents that gov-
ern phase-3 repolarization. In guinea-pig heart, the density of IK, the delayed rectifier, is signif-
icantly less in endocardial than epicardial myocytes [43], and IK1 current (the inward rectifier)
is smaller in RV than LV myocytes [44]. Importantly, the slow component of IK (IKs) is
reduced to a greater extent than the rapid component (IKr), in endocardium vs. epicardium
[43], indicating a greater IKr-to-IKs ratio in endocardial cells. In connection with this, the
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simulations that utilize the guinea-pig ventricular cell model suggest that a larger IKr-to-IKs
ratio contributes to the faster rate of APD changes at short diastolic intervals [26, 45], thus pro-
viding a mechanism for the regional differences in restitution kinetics, at least over transmural
plane.
The recent experimental works increasingly recognize that the steady-state action potential
duration is the principal intrinsic determinant of the restitution slope; a greater basal APD
independently contributes to steepening of the restitution curve [33, 46]. The results from the
present study partly concur with this notion, as the LV endocardium and RV epicardium were
found to exhibit both a longer steady-state APD and a steeper maximum restitution slope,
when compared to those determined at the LV epicardium (Fig 1, panels D and E).
Drug effects
In this study, dofetilide, quinidine, and procainamide prolonged APD to a greater extent at the
long as compared to the short DIs, and therefore steepened the restitution curve (panels A-F
in Figs 2, 4 and 5). The reverse rate-dependent prolongation of APD is an important attribute
of the drug-induced IKr block [47–48], which is relevant to these agents—dofetilide is a specific
IKr blocker [47], whereas quinidine and procainamide, although being categorized as class Ia
INa blockers, can significantly reduce IKr in cardiac cells [49–50]. Owing to the regional varia-
tions in IKr distribution [32, 43], it can be expected that these drugs would affect the APD resti-
tution in spatially non-uniform manner. Indeed, both the reverse rate-dependent APD
lengthening and the resulting increase in the restitution slope by dofetilide, quinidine, and
procainamide were found to be greater in endocardium vs. epicardium, and in RV vs. LV
chamber, thus contributing to the amplified spatial restitution heterogeneities (panels G and H
in Figs 2, 4 and 5).
The prolongation of ventricular repolarization has also been observed with flecainide, the
class Ic Na+ channel blocker that can inhibit IKr in hERG-expressing cell lines [51] and guinea-
pig ventricular myocytes [52]. However, in contrast to dofetilide, quinidine, and procaina-
mide, the APD lengthening by flecainide was not reverse rate-dependent. At LV endocardium
and RV epicardium, a proportional APD increase was elicited by flecainide at variable pacing
rates, whereas at LV epicardium, the APD was actually prolonged to a greater extent at the
short as compared to the long diastolic intervals (Fig 7, panels A-C). As a result, the steepness
of the restitution curve was not changed at LV endocardium and RV epicardium, while being
reduced at LV epicardium (Fig 7, panels D-F). Hence despite a distinct pattern of APD
changes, the flecainide effect on the spatial restitution heterogeneities was similar to those pro-
duced by dofetilide, quinidine, and procainamide–both transmural and RV-to-LV dispersion
of the maximum restitution slope was accentuated by this agent (Fig 7, panels G and H).
The reason for the contrasting effects of flecainide vs. those produced by the other arrhyth-
mogenic drugs on APD rate-dependency is not clear. Nevertheless, it can be hypothesized that
the distinct action of flecainide is partly accounted for by its ability to modify Ca2+ handling in
cardiac myocytes. Flecainide inhibits the ryanodine receptor-mediated Ca2+ release from sar-
coplasmic reticulum, which contributes to its therapeutic action in catecholaminergic poly-
morphic ventricular tachycardia [53–54]. With IKr-blocking agents, the reverse rate-
dependent APD changes are partly determined by the increased magnitude of IKs at fast pacing
rates [47], an effect attributable to both incomplete IKs deactivation, and to the pacing-induced
intracellular Ca2+ accumulation, which acts to increase IKs conductance [26]. Flecainide, by
inhibiting the sarcoplasmic reticulum Ca2+ release, can subsequently attenuate the Ca2
+-dependent increase in IKs, and therefore decrease the amount of APD shortening at fast pac-
ing rates. This mechanism may potentially decrease the maximum restitution slope, or at the
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very least, prevent a steepening of the restitution curve that is expected to result from the con-
comitant IKr-blocking effect of flecainide.
JT intervals in assessments of electrical restitution
The data suggesting that regional restitution heterogeneities can determine arrhythmic vulner-
ability regardless of the steepness of the restitution curve [30, 34, 38, 42] stimulated the
attempts to develop non-invasive ECG markers that quantify spatial dispersion of the restitu-
tion slope [55–56]. The present study expands these efforts by showing that JTpeak vs. JTend
difference in the restitution slope can approximate the regional non-uniformities in APD resti-
tution. The assessments were based on measuring the JT rather than the QT intervals, because
in the setting of delayed ventricular conduction attributable both to the epicardial pacing and
Na+ channel blockers effects, a wide QRS complex can significantly contribute to the overall
QT duration, thus reducing its specificity in detecting repolarization derangements. Clinically,
the risk of incident cardiovascular events is better predicted with measurements of the JT
rather than the QT interval [57–59]. It is also noteworthy that in isolated, perfused hearts, the
QT interval typically grossly exceeds ventricular action potential duration, and the QT is less
sensitive to changes in pacing rate and drug effects, when compared to the corresponding vari-
ations in APD90 [60–61].
In perfused canine ventricular wedge preparations, the end of epicardial action potential
was shown to coincide with the peak of the T wave, whereas full repolarization of the M cells
marks the end of the T wave, meaning that the Tpeak-to-Tend interval is a measure of trans-
mural dispersion of repolarization [13]. Conversely, studies that utilized electroanatomic car-
diac mapping in open-chest dogs and pigs suggest that the Tpeak-to-Tend interval represents
a difference between the earliest and the latest repolarization times determined along all ana-
tomic axes (apicobasal, transmural, interventricular, anterior-posterior) in the whole heart
[14–17]. Thus, even though the precise anatomical location of ventricular cells primarily con-
tributing to the Tend vs. those responsible for the Tpeak on ECG is a matter for debate, it
appears that JTpeak and JTend intervals roughly correspond to the shortest and the longest
action potential durations, respectively, when assessed at multiple ventricular sites. If so, then
the dispersion of electrical restitution along the ventricular sites with variable steady-state
APD should be closely approximated by the JTpeak vs. JTend difference in the rate adaptation
kinetics. In support of this notion, in the present study, the lower value of the maximum resti-
tution slope determined at LV epicardium (0.57±0.02) compared to LV endocardium (0.73
±0.03) and RV epicardium (0.69±0.03), was associated with lesser maximum restitution slope
for the JTpeak (0.58±0.02) vs. the JTend (0.91±0.05) intervals. Furthermore, the spatial disper-
sion of APD90 restitution and the JTend to JTpeak difference in the restitution slope value
were found to increase in parallel upon drug infusions.
Clinical implications. Arrhythmogenic drug effects are often precipitated by sudden
changes in heart rate, e.g. those provoked by exercise [62], or spontaneous onset and termina-
tion of atrial fibrillation [63], raising a possibility that accentuated spatial non-uniformities in
APD rate adaptation contribute to arrhythmic substrate. This study provides an evidence in
support of this notion by demonstrating that both epicardial-to-endocardial and the LV-to-
RV dispersion of the APD90 restitution slope is increased by drugs known to have proarrhyth-
mic potential. Furthermore, the association of the JTend vs. JTpeak restitution with appropri-
ate rate-dependent changes in APD90 implies that spatial restitution heterogeneities could be
assessed indirectly from the surface ECG recordings, for example, during exercise stress tests,
thereby providing a non-invasive marker for stratification of arrhythmic risks in the clinical
setting.
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Importantly, in assessments of arrhythmic susceptibility, the JTpeak vs. JTend restitution
would not simply duplicate some other known ECG metrics of repolarization, such as the
Tpeak-to-Tend interval. Whilst the Tpeak-to-Tend interval is an estimate of the spatial disper-
sion of repolarization at a given heart rate, the JT restitution approximates changes in action
potential duration obtained over a wide range of cardiac beating rates at the ventricular sites
with the earliest (JTpeak) vs. those with the latest (JTend) repolarization times. As such, the
JTpeak vs. JTend restitution slope difference is more integrative metric than the Tpeak-to-
Tend interval in assessments of repolarization dynamics. This difference can be particularly
important in predicting arrhythmia provoked by an abrupt increase in cardiac activation rate.
Notably, in the clinical setting, ambulatory ECG monitoring in victims of sudden death sug-
gests that fatal cardiac arrest is often preceded by transient heart rate acceleration [64–65]. In
tachycardia, owing to a greater JTend than JTpeak shortening (Fig 1, panel F), the Tpeak-to-
Tend interval will be reduced, which may be interpreted as attenuated, rather than increased,
arrhythmic susceptibility. In contrast, as the maximum restitution slope is always measured at
the shortest diastolic intervals with preserved 1:1 capture, the greatest JTpeak vs. JTend slope
difference would be determined at the fast cardiac activation rates, which is consistent with
increased arrhythmic tendency in this setting.
Limitations. Species-related differences in the outward K+ currents that govern cardiac
repolarization should be taken into account when considering the practical aspects of this
study. In human ventricular myocytes, phase-3 repolarization is mostly controlled by IKr,
whereas in guinea-pig it is primarily determined by IKs [66–67]. Likewise, Ito, the transient out-
ward K+ current, which contributes to phase-1 repolarization in the human ventricular action
potential, is not expressed in guinea-pig myocytes [68]. Nevertheless, when considering the
electrical restitution kinetics, one argument in support of the guinea-pig model is that the max-
imum APD restitution slope values determined in this study (Fig 1, panel E) are close to those
measured in human patients [35–36], and the spatial non-uniformities in the maximum resti-
tution slope existing either across LV wall or in RV vs. LV sites in the human hearts [35, 37]
are also present in the guinea-pig model (Fig 1, panels D and E).
This study explored changes in the rate adaptation of ventricular repolarization upon infu-
sion of arrhythmogenic drugs, with particular focus on APD and JT restitution kinetics. With
INa blockers such as flecainide, quinidine, and procainamide, another important proarrhyth-
mic determinant to consider is the restitution of conduction velocity, which determines the
excitation wavelength dynamics [69]. Although drug-induced changes in ventricular conduc-
tion were not examined in the present study, this aspect was addressed in the previous work
[70], which highlighted important differences in class Ia and Ic vs. class Ib Na+ channel block-
ers effects on the restitution of the excitation wavelength.
Conclusions
Local heterogeneities in distribution of the maximum APD90 restitution slope in perfused
guinea-pig heart, and the JTpeak vs. JTend difference in the restitution slope value determined
from ECG, are increased by drugs with arrhythmogenic profiles, such as dofetilide, quinidine,
procainamide, and flecainide.
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